Cangrelor With and Without Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Percutaneous Coronary Intervention

Overview of attention for article published in JACC, January 2017

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (95th percentile)
Above-average Attention Score compared to outputs of the same age and source (62nd percentile)

Mentioned by

news: 2 news outlets
blogs: 1 blog
policy: 1 policy source

twitter: 18 X users
facebook: 2 Facebook pages
guideline: 1 clinical guideline source

Readers on

mendeley: 148 Mendeley

So far, Altmetric has seen 22 X posts from 18 X users, with an upper bound of 100,200 followers.

RT @JACCJournals: Cangrelor reduces periprocedural ischemic complications irrespective of GPI use. #JACC https://t.co/1UPCSlNZ1z https://t.…

RT @CRT_meeting: Three studies suggest #Cangrelor reduces #ischemiccomplications in #PCI patients regardless of #GPI administration. https:…

RT @JACCJournals: Cangrelor reduces periprocedural ischemic complications irrespective of GPI use. #JACC https://t.co/1UPCSlNZ1z https://t.…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 18 additional X posts.